Acuson exhibits IVUS catheter at AHA show

Article

Acuson of Mountain View, CA, demonstrated a 64-channel intravascular ultrasound catheter as a work-in-progress for cardiac imaging at last month's American Heart Association meeting in Dallas. The company believes that the side-fire catheter should be

Acuson of Mountain View, CA, demonstrated a 64-channel intravascular ultrasound catheter as a work-in-progress for cardiac imaging at last month's American Heart Association meeting in Dallas. The company believes that the side-fire catheter should be more versatile than one-channel IVUS catheters.

The catheter is placed in the right atrium for intracardiac imaging and provides better image quality than a transthoracic or transesophageal probe, according to the company. It supports color Doppler, Doppler Tissue Imaging, spectral imaging, and almost all imaging techniques available on the Aspen or Sequoia scanners.

Acuson has an investigational device exemption for the transducer and is conducting clinical trials for the probe. The company plans to file a 510(k) application next year.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.